1A9bnbK

Recommendations

Info

190 THIRD WHO REPORT ON NEGLECTED TROPICAL DISEASES *** Annex 6. Methods used to prepare maps and charts Population The total population of each country is taken from World population prospects: the 2012 revision (1). In some cases, the population of children aged 1–4 years and 5–14 years is also given since these are the age groups specifi cally targeted for anthelminthic treatments. Preventive chemotherapy data Unless otherwise specifi ed, data on preventive chemotherapy are as provided by national authorities to WHO through reporting processes in country and regional offi ces using standardized templates. Maps and charts for lymphatic fi lariasis, soil-transmitted helminthiases, schistosomiasis, onchocerciasis and trachoma were prepared using data reported to WHO annually. Information from the Preventive Chemotherapy and Transmission Control (PCT) databank was used to compile sections of this report, and is accessible online (2). The main defi nitions of data used to describe preventive chemotherapy are as follows: • population requiring preventive chemotherapy – the total population living in all endemic areas that requires preventive chemotherapy; • geographical coverage – the proportion (%) of endemic districts covered by preventive chemotherapy; • programme coverage – the proportion (%) of individuals who were treated according to the programme’s target; • national disease-specific coverage – the proportion (%) of individuals in the population requiring preventive chemotherapy for the specifi c disease that was treated. Dracunculiasis data are reported weekly to WHO by national authorities that provide updates on the status of the eradication initiative at the country level as well as related epidemiological information. Foodborne trematodiases data are based on information obtained from peer-reviewed publications, and supplemented by the opinions of international experts. Innovative and intensified disease-management data Data for neglected tropical diseases in which the large-scale use of existing tools is limited have been obtained by various non-integrated methods that depend on the particulars of the disease-control programme. Details of the data sources are given below. • Buruli ulcer data are reported to WHO annually by national authorities using a standardized template; • Chagas disease data are reported to WHO as offi cial estimates and endorsed through a consultative process among national authorities and international experts; • Endemic treponematoses data are reported to WHO annually by national authorities using a standardized template; • Human African trypanosomiasis data are reported to WHO annually by national authorities using a standardized template; • Leishmaniases data are reported to WHO annually by national authorities using a standardized template; • Leprosy data are reported to WHO annually by national authorities using a standardized template. Vector ecology and management data • Dengue data are reported to WHO annually by national authorities using a standardized template. Veterinary public health data • Cysticercosis data are based on information obtained from peer-reviewed publications, and supplemented by the opinions of international experts; • Echinococcosis data are based on information obtained from peer-reviewed publications and the opinions of international experts; • Rabies data are based on information obtained from peer-reviewed publications, and supplemented by the opinions of international experts. Sources of information for figures and chapters Sources of information are mostly indicated in each fi gure and specifi c chapter. All reasonable precautions have been taken to verify and confi rm the accuracy of the information contained in this publication. REFERENCES 1 World population prospects: the 2012 revision. New York (NY): United Nations Population Division; 2013 (http://esa.un.org/wpp/index.htm; accessed October 2014). 2 PCT databank. Geneva: World Health Organization; 2014 (http://www.who.int/neglected_diseases/preventive_chemotherapy/databank/en/; accessed October 2014).
*** ANNEXES 191 WHO REGIONAL OFFICES Regional Office for Africa Cité du Djoué, P.O. Box 06 Brazzaville, Republic of the Congo Telephone: +47 241 39100 / +47 242 770 02 02 Fax: +47 241 39503 E-mail: postmaster@afro.who.int Regional Office for the Americas 525, 23rd Street, N.W. Washington, DC 20037, USA Telephone: +1 202 974 3000 Facsimile: +1 202 974 3663 E-mail: postmaster@paho.org Regional Office for South-East Asia World Health House Indraprastha Estate Mahatma Gandhi Marg New Delhi 110 002, India Telephone: +91 11 2337 0804 / 2337 0809-11 Facsimile: +91 11 2337 0197 / 2337 9395 / 2337 9507 E-mail: postmaster@searo.who.int Regional Office for Europe Regional Office for Europe UN City, Marmorvej 51 2100 Copenhagen Ø, Denmark Telephone: +45 45 33 7000 Facsimile: +45 45 33 7001 E-mail: postmaster@euro.who.int Regional Office for the Eastern Mediterranean Monazamet El Seha El Alamia Street Extension of Abdel Razak El Sanhouri Street P.O. Box 7608, Nasr City Cairo 11371, Egypt Telephone: +20 2 2276 5000 Fax: +20 2 2670 2492 / +20 2 2670 2494 E-mail: postmaster@emro.who.int Regional Office for the Western Pacific P.O. Box 2932 1000 Manila, Philippines Telephone: +63 2 528 8001 Fax: +63 2 521 1036 / 526 0279 E-mail: postmaster@wpro.who.int
Page 1:
INVESTING TO OVERCOME THE GLOBAL IM
Page 4 and 5:
ii THIRD WHO REPORT ON NEGLECTED TR
Page 6 and 7:
iv THIRD WHO REPORT ON NEGLECTED TR
Page 8:
vi THIRD WHO REPORT ON NEGLECTED TR
Page 11 and 12:
*** FOREWORD ix FOREWORD BY THE DIR
Page 13 and 14:
*** EXECUTIVE SUMMARY xi EXECUTIVE
Page 15 and 16:
*** EXECUTIVE SUMMARY xiii for the
Page 17 and 18:
*** EXECUTIVE SUMMARY xv Neglected
Page 19 and 20:
*** THE RESOLUTION AND THE ROADMAP
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
*** INVESTING TOWARDS UNIVERSAL COV
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
● ● ● ● ● ● ● ● ●
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
*** KEY INTERVENTIONS: SITUATION RE
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
*** THE DISEASES − CHAPTER 4 69 I
Page 89 and 90:
Page 91 and 92:
*** THE DISEASES − CHAPTER 4 73 p
Page 93 and 94:
*** THE DISEASES − CHAPTER 4 75 4
Page 95 and 96:
*** THE DISEASES − CHAPTER 4 77 E
Page 97 and 98:
*** THE DISEASES − CHAPTER 4 79 T
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
*** THE DISEASES − CHAPTER 4 85 A
Page 105 and 106:
*** THE DISEASES − CHAPTER 4 87 F
Page 107 and 108:
Page 109 and 110:
*** THE DISEASES − CHAPTER 4 91 F
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
*** THE DISEASES − CHAPTER 4 99 M
Page 119 and 120:
*** THE DISEASES − CHAPTER 4 101
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158: *** THE DISEASES − CHAPTER 4 139
Page 197 and 198: *** ANNEXES 179 ANNEXES
Page 199 and 200: *** ANNEXES 181 Annex 1a (cont’d)
Page 201 and 202: *** ANNEXES 183 WHA66.12 Recognizin
Page 203 and 204: *** ANNEXES 185 WHA66.12 3. REQUEST
Page 205 and 206: *** ANNEXES 187 Annex 3. Classifica
Page 207: *** ANNEXES 189 Annex 5. Medicines
show all

1A9bnbK

Create successful ePaper yourself

Delete template?

Save as template?